ScrutarSign up free

ECOLAB INC. (ECL)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEMaterialsChemicals

Ecolab Inc., incorporated in Delaware in 1924, is a global sustainability leader providing water, hygiene, and infection prevention solutions and services across more than 170 countries, generating approximately $14 billion in annual sales and employing more than 47,000 associates. The company completed the split-off of its Upstream Energy (ChampionX) business in June 2020 via a Reverse Morris Trust transaction, which is reported as discontinued operations, and in December 2021 acquired Purolite, a global provider of ion exchange resins for separation and purification used in life sciences and industrial markets, for $3.7 billion. Ecolab pursues a "Circle the Customer – Circle the Globe" strategy, delivering science-based solutions, digital technologies, and services that help customers in food, healthcare, life sciences, hospitality, and industrial markets improve operational efficiency, food safety, and sustainability, including water and energy conservation and greenhouse gas emission reduction.

The company organizes its operations into three reportable segments—Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences—plus an "Other" category. Global Industrial includes Water (treatment for cooling, boiler, wastewater and process applications), Food & Beverage (cleaning/sanitizing for dairy, beverage, and food processing), Downstream (chemical solutions for petroleum refining and petrochemicals), and Paper (water and process treatments for pulp and paper production). Global Institutional & Specialty comprises Institutional (warewashing, laundry, housekeeping, and food-safety products for foodservice, hospitality, and healthcare) and Specialty (cleaning and sanitizing products for quick-service restaurants and food retailers under the Ecolab and Kay brands).

Global Healthcare & Life Sciences includes Healthcare (infection prevention and surgical solutions for hospitals, sold under Ecolab, Microtek, and Anios brands) and Life Sciences (cleaning, contamination control, and purification solutions for pharmaceutical and personal care manufacturers, including Purolite and Bioquell brands). The Other category comprises Pest Elimination (pest control services for commercial and institutional clients), Textile Care (laundry management programs for commercial operations), and Colloidal Technologies Group (colloidal silica products for semiconductor, catalyst, and industrial applications). Ecolab operates internationally in approximately 100 countries outside the U.S. through wholly owned subsidiaries and joint ventures, facing typical foreign operational risks and generally lower international profitability due to higher costs and smaller scale abroad.

The company competes across its segments against a mix of large multinational firms and smaller regional players, differentiating itself through technical expertise, digital innovation, and comprehensive customer service.

AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.

RevenueFY2023
$15.32B
▲ 8.0%YoY
Net incomeFY2023
$1.37B
▲ 25.7%YoY
Diluted EPSFY2023
$4.79
▲ 25.7%YoY
Gross margin
40.2%
▲ 249 bpsYoY
Insider net6 mo
+4.2K
shares5 sells5 buys
Institutions
47
$37.26B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
-$5B$5B$10B$15B$20B
FY2020FY2021FY2022FY2023
RevenueNet income
FY2023 highlightsfrom 10-K
Gross profit$6.17B
Operating income$1.99B
Diluted EPS$4.79
Gross margin40.2%
Net margin9.0%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
4ZILLMER JOHN JOct 2, 2026EDGAR
4Whalen JulieOct 2, 2026EDGAR
4Vautrinot Suzanne MOct 2, 2026EDGAR
4NOWELL LIONEL L IIIOct 2, 2026EDGAR
4McKibben Tracy BOct 2, 2026EDGAR
4MacLennan DavidOct 2, 2026EDGAR
4LARSON MICHAELOct 2, 2026EDGAR
4Gross Marion K.Oct 2, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Althoff JudsonSep 30, 2026Grant / award
Ballard Shari LSep 30, 2026Grant / award
Doukeris Michel DSep 30, 2026Grant / award
Green Eric MarkSep 30, 2026Grant / award
Gross Marion K.Sep 30, 2026Grant / award

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
BlackRock, Inc.8.2%Aug 7, 2026$6.42B
Vanguard Capital Management5.9%Aug 13, 2026$4.61B
JPMORGAN CHASE & CO5.2%Aug 12, 2026$4.07B
STATE STREET CORPORATION4.2%Sep 22, 2026$3.29B
MORGAN STANLEY2.8%Aug 13, 2026$2.18B

ECL's filings are public. The insight is one click away.

Scrutar's AI reads every ECL filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze ECL filingsNo credit cardAI reports included on the free plan

Never miss a ECL filing.

Get an email when ECL files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Oct 15, 2026Source: SEC EDGAR.